Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: science  women  lls  leukemia  lymphoma  equal  cancer  research  stem  multivu  8128552  cure  blood  cancer  health  medical  research  leukemia  lymphoma  treatment  multivu  8128551  st  jude  children  research  hospital  medical  treatment  cancer  leukemia  illnesses  multivu  7924755  research  blood  cancer  cancer  cure  treatment  health  medical  grants  fund  multivu  7554855  cancer  leukemia  lymphoma  lls  health  healthcare  cure  treatment  aml  multivu  7554854  health  cancer  leukemia  lymphoma  charity  research  lifesaving  children  fundraising  multivu  7554853  pharmaceutical  research  manufacturing  health  cure  cancer  leukemia  cure  medical  multivu  7738431  johnson  johnson  biopharmaceutical  idea  pharma  neuroscience  medicine  health  innovation  multivu  7770851  northwestern  mutual  parade  float  rose  bowl  football  collage  awareness  child  cancer  multivu  7422155  leukemia  lymphoma  society  health  medical  therapy  research  cancer  treatments  disease  multivu  7554852  cancer  northwestern  mutual  rose  parade  honda  children  childhood  disease  leukemia  multivu  7422154  leukemia  lymphoma  nonprofit  cancer  health  blood  cancer  research  awareness  lls  multivu  7554851 
Search // leukemia
Results 1-12 of 24 for ' leukemia ' (7 seconds)
As breakthroughs in cancer treatments are occurring at an ever increasing rate, The Leukemia & Lymphoma Society (LLS) is shining a spotlight on the women in science who are helping to lead these advances. Through its significant investment in cancer research – more than $1.2 billion since its founding nearly 70 years ago – LLS is committed to funding and recognizing female scientists, physicians, social workers and nurses, and encouraging young women to participate in STEM (science, technology, engineering and math) education and pursue careers in the sciences. To view the multimedia release go to: https://www.multivu.com/players/English/8128552-lls-women-in-science/
Categories // Miscellaneous 
Added: 218 days ago by MultiVuVideos
Runtime: 0m45s | Views: 5 | Comments: 4
Not yet rated
 

 

 

Blood cancers are the third leading cause of cancer deaths in the U.S. However, many Americans are unaware of the impact of these cancers, including leukemia, lymphoma and myeloma, which affect the bone marrow, the blood cells, the lymph nodes and other parts of the lymphatic system. A new survey commissioned by The Leukemia & Lymphoma Society (LLS) reveals more than four in five adults (82%) are surprised that blood cancers are the third leading cancer killer of Americans. Further, nearly four in five adults (78%) are surprised that acute lymphocytic leukemia (ALL) is the most common cancer in children and young adults under age 20. To view the multimedia release go to: https://www.multivu.com/players/English/8128551-lls-blood-cancer-awareness-month/
Categories // Miscellaneous 
Added: 412 days ago by MultiVuVideos
Runtime: 4m47s | Views: 6 | Comments: 0
Not yet rated
 

 

 

St. Jude Children’s Research Hospital patients who completed kindergarten during their treatment for pediatric cancers celebrated at a graduation ceremony. For the 10th straight year, St. Jude honored 14 patients from around the United States who completed kindergarten while battling life-threatening illnesses like leukemia and brain tumors. Dozens of families and St. Jude doctors, nurses, and staff cheered for the young students, who completed kindergarten in the St. Jude School Program by Chili’s. Each year, the school program commemorates students who have completed kindergarten coursework with a special ceremony. The children present a song for the families and St. Jude staff, receive their diplomas and celebrate the milestone with their fellow students. To view the multimedia release go to: https://www.multivu.com/players/English/7924755-st-jude-celebrates-kindergarten-graduation/
Categories // Miscellaneous 
Added: 505 days ago by MultiVuVideos
Runtime: 1m23s | Views: 4 | Comments: 0
Not yet rated
 

 

 

The Leukemia & Lymphoma Society (LLS) today announced it has committed $40.3 million in new research investments to advance the most promising blood cancer science at leading academic and medical centers around the world, including Dana-Farber Cancer Institute in Boston; Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in New York; MD Anderson Cancer Center in Houston; Fondazione Centro San Raffaele in Milan; and South Australian Health & Medical Research Institute in Adelaide. This $40.3 million investment, comprised of 75 new research grants in LLS’s portfolio of 300 projects, will fund a diverse array of research to find better treatments and cures for patients with leukemia, lymphoma, myeloma and other blood cancers. To view the multimedia release go to: http://www.multivu.com/players/English/7554855-lls-invests-millions-new-research-treatment-cures/
Categories // Miscellaneous 
Added: 700 days ago by MultiVuVideos
Runtime: 0m47s | Views: 71 | Comments: 0
Not yet rated
 

 

 

Going on the offensive against one of the most daunting challenges in cancer, The Leukemia & Lymphoma Society (LLS) today announced the launch of a groundbreaking, collaborative clinical trial for acute myeloid leukemia (AML), a deadly disease which has seen few improvements in treatments in more than 40 years. Beat AML was announced yesterday by Vice President Biden, along with many new, Moonshot inspired initiatives across industry, non-profit and government. AML is the most lethal of the blood cancers, which together are the third leading cause of cancer deaths in the U.S.; AML is responsible for more than 10,000 deaths each year. Despite advances in treating other blood cancers, the standard of treatment for AML – a combination of toxic chemotherapies – has remained the same for more than 40 years. Overall prognosis remains poor, with a five-year survival rate below 20 percent for patients over age 60. To view the multimedia release go to: http://www.multivu.com/players/English/7554854-lls-beat-aml-acute-myeloid-leukemia/
Categories // Miscellaneous 
Added: 729 days ago by MultiVuVideos
Runtime: 0m59s | Views: 75 | Comments: 0
Not yet rated
 

 

 

Team In Training. Light The Night. Man & Woman of the Year. Student Series. Leukemia Cup Regatta. More than 13 million participants in these popular fundraising campaigns last year alone helped The Leukemia & Lymphoma Society (LLS) invest more than $1 billion in research to advance lifesaving treatments and cures for blood cancer patients. For Blood Cancer Awareness Month this September, LLS is reminding us that despite progress, much work still needs to be done to save more lives. More than 1.2 million people in the U.S. are living with or in remission from a blood cancer. Leukemia causes more deaths than any other cancer among children, adolescents and adults younger than 20 years. Leukemia, lymphoma and myeloma are expected to cause the deaths of an estimated 58,320 people in the U.S. in 2016. To view the multimedia release go to: http://www.multivu.com/players/English/7554853-lls-blood-cancer-awareness-month/
Categories // Miscellaneous 
Added: 777 days ago by MultiVuVideos
Runtime: 1m0s | Views: 132 | Comments: 0
Not yet rated
 

 

 

The Pharmaceutical Research and Manufacturers of America (PhRMA) today released new advertising as part of its “From Hope to Cures” campaign, highlighting the stories of rare blood and lung cancer survivors. The newest video in the collection features Matt, who was diagnosed nearly seven years ago with advanced non-small cell lung cancer. When he was diagnosed, he was given a slim chance of living up to five years. However, today Matt continues to lead an active life due to recent advancements in targeted gene therapies and innovations in cancer medicines. The latest print and digital ads feature Jamie, a vibrant woman diagnosed 15 years ago with chronic myelogenous leukemia (CML). Watching her son grow up was a primary focus for her, and she’s been able to continue to do that and so much more. Thanks to advancements in CML treatments, today she maintains her sense of humor and imparts an infectious joy on those who meet her. Earlier this year, the first collection of digital and print ads was released featuring Rhys, a five-year-old living with type 1 diabetes and celiac disease. Unveiled alongside the advertising was a video, titled “We’re Fighting Back,” which features both Rhys and Jamie, as well as Jen, a researcher who wakes up every day working to find new treatments and cures for patients. To view the multimedia release go to: http://www.multivu.com/players/English/7738431-phrma-from-hope-to-cures/
Categories // Miscellaneous 
Added: 912 days ago by MultiVuVideos
Runtime: 0m30s | Views: 119 | Comments: 0
Not yet rated
 

 

 

The sixth annual Productive Innovation Index released by IDEA Pharma today, which ranks biopharmaceutical companies by their ability to successfully bring innovations to market, sees Johnson & Johnson top the industry for the fourth year running. The Productive Innovation Index measures, scores and celebrates a company’s ability to deliver innovation to patients, by objectively evaluating performance data based on a rolling five year period (2010-2015), and operates on the premise: if you gave the same molecule to two different companies in early phase, which would make the best of it? The success of the Janssen Pharmaceutical Companies of Johnson & Johnson and its consolidation of 1st place across the past four years’ rankings is driven largely by innovations in the field of oncology, immunology, neuroscience and cardiovascular/metabolism. Notable performers include Zytiga® (prostate cancer), Imbruvica® (chronic lymphocytic leukemia and mantle cell lymphoma (co-developed and co-marketed with Pharmacyclics, an AbbVie company)), Simponi®/Simponi Aria® (rheumatoid arthritis), Stelara® (psoriasis and psoriatic arthritis), Invega Sustenna® and Invega Trinza® (schizophrenia). To view the multimedia release go to: http://www.multivu.com/players/uk/7770851-johnson-and-johnson-tops-idea-pharma/
Categories // Miscellaneous 
Added: 965 days ago by MultiVuVideos
Runtime: 3m36s | Views: 159 | Comments: 0
Not yet rated
 

 

 

Northwestern Mutual, presenting sponsor of the 2016 Rose Bowl Game®, today unveiled its float design for the 127th Rose Parade® presented by Honda. Titled Dancing into Adventure, it will draw attention to the fight against childhood cancer by showcasing the greatest adventure and dream of Peyton Richardson, a 13-year-old aspiring ballerina from Sugar Land, Texas, who is battling leukemia. The theme of this year’s parade is Find Your Adventure. As an aspiring ballerina, Peyton wants to travel the world to see performances from the world’s most distinguished ballet companies and have a dance lesson with their principal dancers. Northwestern Mutual is using its sponsorship to bring Peyton’s adventure to life in flowers and raise awareness about childhood cancer. “Peyton’s unique, positive way of using ballet to battle cancer and stay focused on her dream is truly amazing,” said Conrad York, vice president of marketing at Northwestern Mutual. “At Northwestern Mutual, we know that each family has a dream in mind for their future, and we are here to support them every step of the way.” To view the multimedia release go to: http://www.multivu.com/players/English/7422155-northwestern-mutual-rose-parade-float/
Categories // Miscellaneous 
Added: 1050 days ago by MultiVuVideos
Runtime: 2m48s | Views: 189 | Comments: 0
Not yet rated
 

 

 

The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers. Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep. To view the multimedia release go to: http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
Categories // Miscellaneous 
Added: 1113 days ago by MultiVuVideos
Runtime: 1m4s | Views: 204 | Comments: 0
Not yet rated
 

 

 

Northwestern Mutual, presenting sponsor of the Rose Bowl Game, today announced that its float in the 127th Rose Parade presented by Honda in Pasadena on Jan. 1, 2016, will support the fight against childhood cancer. The theme of this year’s parade is Find Your Adventure. Northwestern Mutual will dedicate its float design to the greatest adventure and dream of 13-year-old Peyton Richardson of Sugar Land, Texas, who is in treatment for acute lymphocytic leukemia (ALL). Northwestern Mutual is committed to raising awareness, accelerating the search for cures to childhood cancer and providing support to families battling the disease. Peyton, an aspiring ballerina, would like to see the performances of the distinguished ballet companies of the world and have a ballet lesson with one of their principal dancers. Peyton’s adventure will be brought to life in flowers by Fiesta Parade Floats. To view the multimedia release go to: http://www.multivu.com/players/English/7422154-northwestern-mutual-rose-bowl/
Categories // Miscellaneous 
Added: 1134 days ago by MultiVuVideos
Runtime: 1m32s | Views: 235 | Comments: 0
Not yet rated
 

 

 

The Leukemia & Lymphoma Society (LLS), the world’s leading voluntary non-profit dedicated to blood cancers, released 30 “proof points” - one for each day of September, Blood Cancer Awareness Month - to demonstrate its impact on the cancer landscape and progress towards a world without blood cancers. LLS has invested more than $1 billion in research to advance breakthrough therapies and cures for blood cancer patients. In many cases, those treatments are now helping patients with other cancers and chronic diseases. Due to its focus on blood cancers, survival rates are improving. Since the early 1960s, five-year survival rates for many blood cancer patients have doubled, tripled and even quadrupled. To view the multimedia release go to: http://www.multivu.com/players/English/7554851-lls-blood-cancer-awareness-month/
Categories // Miscellaneous 
Added: 1143 days ago by MultiVuVideos
Runtime: 0m32s | Views: 193 | Comments: 0
Not yet rated
 

 

 

Page 1 of 2  |  Go to page    Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2018 ClipMoon.com. All rights reserved.